Post

EI

Endo International plc (Dublin, Ireland). Acquired by Pharma & Co. (2024). Supprelin, Xiaflex, Lidoderm. Generic sterile injectables. Par Pharmaceutical generics. Specialty: urology, orthopedics.

Our green solvents platform developed cyrene as a renewable alternative to NMP.

9:17:04 PM · Jul 9, 2026
Sign in to reply and join the conversation.